Study to Evaluate Pharmacokinetics, Safety and Efficacy of CM310

This is a single-center, randomized, open study to evaluate the pharmacokinetics, safety and immunogenicity CM310 in healthy subjects.

Inclusion Criteria:Have the ability to understand the study.Voluntarily participate in the study and sign the ICF.18 years ≤ age ≤ 65 years, male and female.Willing to take effective contraceptive measures during the study period.Exclusion Criteria:Plan to receive any major surgery during the study period.With malignant tumors within 5 years before screening.Positive results of alcohol breath test or urine drug abuse screening during screening period.Any reason that the investigator believes that will prevent the subject from participating in the study.